Title:
ANTI-PODOPLANIN ANTIBODY AND ANTIBODY-DRUG COMPLEX
Document Type and Number:
WIPO Patent Application WO/2017/026502
Kind Code:
A1
Abstract:
Provided is an anti-podoplanin antibody having high binding activity and effector activity. A human chimera or humanized anti-podoplanin monoclonal antibody having rodent-derived CDR in the variable region and a human-derived constant region, wherein the human chimera or humanized anti-podoplanin monoclonal antibody has a human λ chain constant region in the light chain constant region.
Inventors:
KATO YUKINARI (JP)
KATO MIKA (JP)
NISHIOKA YASUHIKO (JP)
ABE SHINJI (JP)
SANO HIROAKI (JP)
FUJIMOTO OSUKE (JP)
KATO MIKA (JP)
NISHIOKA YASUHIKO (JP)
ABE SHINJI (JP)
SANO HIROAKI (JP)
FUJIMOTO OSUKE (JP)
Application Number:
PCT/JP2016/073516
Publication Date:
February 16, 2017
Filing Date:
August 10, 2016
Export Citation:
Assignee:
UNIV TOHOKU (JP)
UNIV TOKUSHIMA (JP)
FUJIFILM RI PHARMA CO LTD (JP)
UNIV TOKUSHIMA (JP)
FUJIFILM RI PHARMA CO LTD (JP)
International Classes:
C07K16/30; A61K39/395; A61K51/00; A61P13/12; A61P35/00; C12N15/09; C12P21/08
Domestic Patent References:
| WO2011040565A1 | 2011-04-07 | |||
| WO2015053381A1 | 2015-04-16 |
Foreign References:
| JP2008154468A | 2008-07-10 | |||
| US20140017266A1 | 2014-01-16 |
Attorney, Agent or Firm:
THE PATENT CORPORATE BODY ARUGA PATENT OFFICE (JP)
Download PDF: